Immune to Cancer: The CRI Blog
-
Immunotherapy is Here to Stay: Looking Back at this Year’s Breakthroughs
Important immunotherapy breakthroughs benefited patients immensely in 2017 and paved the way for even more advances in…
-
CICON17 Day 1 Recap: Neoantigens, Vaccines, and Overcoming Immunotherapy Resistance
Day 1 of CICON17 explored how to identify and target neoantigens with vaccines and other strategies to…
-
AACR17 Update: CAR T Cells, Regulatory T Cells, and the Future of Immunotherapy
Day two addressed several strategies to improve immunotherapy’s precision and effectiveness
-
New Study: Vaccine Holds Promise in Treating Cervical Pre-Cancer
The vaccine could provide a new treatment option for patients with high-risk cervical pre-cancer.
-
Found: A Molecular Needle in the Cancer Haystack
New research by CRI scientists shows how genomic methods can be used to create a personalized cancer…
-
Making Pancreatic Cancer a Target for Immunotherapy
Researchers show that pancreatic cancer, long known to resist immunotherapy, can be made immunogenic after all.
-
Breast Cancer Vaccine Shows Success for Treating Osteosarcoma in Dogs
A cancer immunotherapy originally designed for treating breast cancer in people may also be effective for treating…
-
New Treatment Strategy Coaxes Cancer Out of Hiding
Recent published findings by CRI scientist Dr. Kunle Odunsi show combination of chemotherapy and a cancer vaccine…
-
The Power of Immunotherapy for Gynecologic Cancers
September is Gynecologic Awareness Month. Of all gynecologic cancers, ovarian is one of the major types for…